Clinical Lymphoma & Myeloma

Phase II Evaluation of Gemcitabine Monotherapy for Cutaneous T-Cell Lymphoma

Madeleine Duvic, Rakhshandra Talpur, Sijin Wen et al. · 2006 · 152 citations

Medicine, Oncology, Pharmacology +13

Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia

Eva Kimby, Steven P. Treon, Athanasios K. Anagnostopoulos et al. · 2006 · 113 citations

Medicine, Hematology, Internal Medicine +2

Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors

Meletios Α. Dimopoulos, Maria Gavriatopoulou, Flora Zagouri et al. · 2009 · 111 citations

Pharmacy, Nephrology, Pharmacotherapy +17

Promoter Hypermethylation of the MEG3 (DLK1/MEG3) Imprinted Gene in Multiple Myeloma

Leonidas Benetatos, Aggeliki Dasoula, Eleftheria Hatzimichael et al. · 2008 · 100 citations

Life Sciences, Genetics, Oncology +14

Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma

Madeleine Duvic, Elise A. Olsen, Debra Breneman et al. · 2009 · 97 citations

Medicine, Oncology, Pharmacotherapy +11